NCT04957485Phase 2Active not recruiting

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Study sponsor: SIGA Technologies

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-01-01Estimated
Enrollment · participants100Actual
Source updated2026-09-14Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

1 Jan 2026

+ After

1 Jan 2027

Check registry source